“…Compared to US, MRI provides excellent visualization of the prostate gland with its substructures, focal lesions within the gland, and surrounding periprostatic tissues, and is widely believed to be the ideal modality for imaging prostate cancer (Beyersdorff et al 2002). In the recent years, researchers have been investigating the clinical utility of MRI for targeted biopsy by fusing the preprocedurally acquired MRI with the intra-procedural US (Ukimura et al 2010, Natarajan et al 2011) or by means of intraoperative MRI for needle and anatomy visualization (Cormack et al 2000, D’Amico et al 2000, Hata et al 2001, Beyersdorff et al 2002, Susil et al 2003, Susil et al 2004, Menard et al 2004, Krieger et al 2005, Zangos et al 2005, Susil et al 2006, Engelhard et al 2006, Blumenfeld et al 2007, de Oliveira et al 2008, Hambrock et al 2008, Rea et al 2008, Lakosi et al 2009, Oguro et al 2009, Menard et al 2010, Menard et al 2011, Yakar et al 2011, Zangos et al 2011, Schouten et al 2012). While US-guided biopsy has been emerging because of its availability, portability, and the recent progress in imaging quality of US, MRI-guided biopsy has the advantages of better soft tissue contrast and applicability to patients who cannot undergo TRUS-guided biopsy due to previous total colectomy.…”